Structural Characterization, Kinetic Studies, and in Vitro Biological Activity of Newcis-Diamminebis-cholylglycinate(O,O‘) Pt(II) andcis-Diamminebis-ursodeoxycholate(O,O‘) Pt(II) Complexes
- 24 February 2000
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 11 (2) , 167-174
- https://doi.org/10.1021/bc9901088
Abstract
The complexes cis-diamminebis-cholylglycinate (O,O‘) [Pt(II) C52H90N4O12Pt, for convenience referred to as Bamet-R1] and cis-diamminebis-ursodeoxycholate (O,O‘) Pt(II) (C48H84N2O8Pt, Bamet-UD2) were prepared. The structural integrity of the compounds was confirmed by elemental analysis, FT-IR, NMR, FAB-MS, and UV spectroscopies. The kinetic study of both compounds was accomplished by combining the conductivity measurement and those of the analysis of the electronic spectra in aqueous solution for NaCl concentrations of 4 mM (similar to cytoplasmatic concentration), 150 mM (similar to plasmatic concentration), and 500 mM. In water, the compound Bamet-R1 showed a half-life, t1/2, of 3.0 h. This compound forms the chelate species through loss of a ligand, and the other one acts as a bidentate ligand. Ring opening in the presence of chloride ion was produced with a kCl−of 0.25 M-1 h-1. The half-life of Bamet-UD2 in aqueous solution was 3.2 h. However, since this species is not able to chelate and has a lower degree of solubility in the presence of chloride ion, its kinetic behavior was very different from that of the other compound. We consider this to be of great interest with regards to its cytostatic activity. All kinetic measurements were performed under pseudo-first-order conditions, and a pseudo-first-order behavior was found. The antitumoral effect of Bamet-UD2 on several cell lines derived from rat hepatoma, human hepatoma, mouse leukemia, and human colon carcinoma was found to be, in general, similar to that of cisplatin, but higher than that observed for Bamet-R1.Keywords
This publication has 12 references indexed in Scilit:
- Cisplatin-based Anticancer AgentsPublished by Royal Society of Chemistry (RSC) ,1999
- Synthetic Ways to Tris(nucleobase) Complexes Derived from cis-Diammineplatinum(II) and a Platinum(II) Complex Containing Four Different Ligands, Three of Which Are NucleobasesInorganic Chemistry, 1998
- Donor atom preferences in complexes of platinum and palladium with amino acids and related moleculesCoordination Chemistry Reviews, 1997
- Synthesis and Characterization of the New Cytostatic Complex cis-Diammineplatinum(II)−ChlorocholylglycinateBioconjugate Chemistry, 1997
- Preparation, characterization, and antitumor activity of new ethylenediamine platinum(IV) complexes containing mixed carboxylate ligandsJournal of Inorganic Biochemistry, 1993
- Synthesis and biological studies of new lipid-soluble cisplatin analogues entrapped in liposomesJournal of Inorganic Biochemistry, 1992
- Synthesis and Characterization of Highly Lipophilic Antitumor Platinum(II) ComplexesJournal of Coordination Chemistry, 1991
- Reactions of platinum(II) aqua complexes. 3. Multinuclear (nitrogen-15, platinum-195, carbon-13, and proton) NMR study of reactions of aqua and hydroxo complexes with glycine and (methylimino)diacetic acidInorganic Chemistry, 1985
- Analysis of conjugated bile acids by high performance liquid chromatography and mass spectrometryLipids, 1983
- Infrared spectra of some platinum(II) glycine complexesJournal of Inorganic and Nuclear Chemistry, 1967